HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Valls, C. Articles by Jorba, R. Search for Related Content PubMed PubMed Citation Articles by Valls, C. Articles by Jorba, R. Social Bookmarking                      What's this?

Dual-Phase Helical CT of Pancreatic Adenocarcinoma

Assessment of Resectability Before Surgery

¹ Institut de Diagnòstic per la Imatge, Hospital Duran i Reynals, Ciutat Sanitària i Universitària de Bellvitge, Autovia de Castelldefels km 2, 7, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
² Department of Surgery, Hospital Princeps d'Espanya Ciutat Sanitaria i Universitaria de Bellvitge, C/Feixa Llarga s/n, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
³ Department of Pathology, Hospital Princeps d'Espanya, 08907 Barcelona, Spain.

OBJECTIVE. The aim of our study was to prospectively evaluate the accuracy of dual-phase helical CT in the preoperative assessment of resectabiliy in patients with suspected pancreatic cancer using surgical and histopathologic correlation.

SUBJECTS AND METHODS. Between January 1999 and December 2000, 76 patients with suspected pancreatic cancer underwent preoperative evaluation and staging with dual-phase helical CT (3-mm collimation for pancreatic phase, 5-mm collimation for portal phase). Iodinated contrast material was injected IV (170 mL at a rate of 4 mL/sec); acquisition began at 40 sec during the pancreatic phase and at 70 sec during the portal phase. Three radiologists prospectively evaluated the imaging findings to determine the presence of pancreatic tumor and signs of unresectability (liver metastasis, vascular encasement, or regional lymph nodes metastasis). The degree of tumor—vessel contiguity was recorded for each patient (no contiguity with tumor, contiguity of <50%, or contiguity of 50%).

RESULTS. Thirty-nine patients with pancreatic adenocarcinoma were surgically explored. Curative resections were attempted in 34 patients and were successful in 25. The positive predictive value for resectability was 73.5%. Nine patients considered resectable on the basis of CT findings were found to be unresectable at surgery because of liver metastasis (n = 5), vascular encasement (n = 2), or lymph node metastasis (n = 2). We found that the overall accuracy of helical CT as a tool for determining whether a pancreatic adenocarcinoma was resectable was 77% (30/39 patients).

CONCLUSION. Dual-phase helical CT is a useful technique for preoperative staging of pancreatic cancer. The main limitation of CT is that it may not reveal small hepatic metastases.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M.-P. Vullierme, M. Giraud-Cohen, P. Hammel, A. Sauvanet, A. Couvelard, D. O'Toole, P. Levy, P. Ruszniewski, and V. Vilgrain Malignant Intraductal Papillary Mucinous Neoplasm of the Pancreas: In Situ versus Invasive Carcinoma Surgical Resectability Radiology, November 1, 2007; 245(2): 483 - 490. [Abstract] [Full Text] [PDF]

				S. K. Maithel, K. Khalili, E. Dixon, M. Guindi, M. P. Callery, M. S. Cattral, B. R. Taylor, S. Gallinger, P. D. Greig, D. R. Grant, et al. Impact of Regional Lymph Node Evaluation in Staging Patients With Periampullary Tumors Ann. Surg. Oncol., January 1, 2007; 14(1): 202 - 210. [Abstract] [Full Text] [PDF]

				G. R. Varadhachary, E. P. Tamm, J. L. Abbruzzese, H. Q. Xiong, C. H. Crane, H. Wang, J. E. Lee, P. W. T. Pisters, D. B. Evans, and R. A. Wolff Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy Ann. Surg. Oncol., August 1, 2006; 13(8): 1035 - 1046. [Abstract] [Full Text] [PDF]

				G. Y. Yang, T. D. Wagner, M. Fuss, and C. R. Thomas Jr. Multimodality Approaches for Pancreatic Cancer CA Cancer J Clin, November 1, 2005; 55(6): 352 - 367. [Abstract] [Full Text] [PDF]

				A. Kobayashi, T. Yamaguchi, T. Ishihara, T. Ohshima, I. Ohno, K. Seza, Y. Shirai, K. Sudo, A. Nakagawa, H. Tadenuma, et al. Assessment of Portal Vein Invasion in Pancreatic Cancer by Fusion 3-Dimensional Ultrasonography J. Ultrasound Med., March 1, 2005; 24(3): 363 - 369. [Abstract] [Full Text] [PDF]

				S Fenchel, T R Fleiter, A J Aschoff, R van Gessel, H-J Brambs, and E M Merkle Effect of iodine concentration of contrast media on contrast enhancement in multislice CT of the pancreas Br. J. Radiol., October 1, 2004; 77(922): 821 - 830. [Abstract] [Full Text] [PDF]

				L. P. Lawler, K. M. Horton, and E. K. Fishman Peripancreatic Masses That Simulate Pancreatic Disease: Spectrum of Disease and Role of CT RadioGraphics, September 1, 2003; 23(5): 1117 - 1131. [Abstract] [Full Text] [PDF]